Methyl 2-oxopiperidine-3-carboxylate

Catalog No.: 
ACKDRX863
CAS No.: 
106118-94-9
Molecular Formula: 
C7H11NO3
Molecular Weight: 
157.17
Methyl 2-oxopiperidine-3-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$65.00In stockInquiry
5g95%$154.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 2-oxopiperidine-3-carboxylate
IUPAC Namemethyl 2-oxopiperidine-3-carboxylate
MDL No.MFCD03410215
Molecular FormulaC7H11NO3
Molecular Weight157.17
SMILESO=C(C1C(NCCC1)=O)OC
InChI KeyBLSIWVNWHCXOCL-UHFFFAOYSA-N
SynonymAS-67557 | AKOS016347381 | STK772130 | 2-Oxopiperidine-3-carboxylic acid, methyl ester | HMS1551G20 | SCHEMBL2789189 | AKOS001752186 | CS-0044685 | methyl2-oxopiperidine-3-carboxylate | 2-Oxo-piperidine-3-carboxylic acid methyl ester | TimTec1_006136 | me
CAS No.106118-94-9
PubChem CID3981101

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACKDRX863 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. ACXYZL236 route compound structure diagram
    ACXYZL23641888-21-5In Stock
  4. Then
  5. ACKDRX863 route product structure diagram
    ACKDRX863106118-94-9In Stock
Inquiry

2. ACKDRX863 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKDRX863 route product structure diagram
    ACKDRX863106118-94-9In Stock
Inquiry

3. ACKDRX863 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKDRX863 route product structure diagram
    ACKDRX863106118-94-9In Stock
Inquiry

Comments (0)